Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Mary-Margaret Keating"'
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 1745-1759 (2023)
Marginal zone lymphomas (MZL) are a rare, heterogenous group of lymphomas, accounting for 5–17% of indolent non-Hodgkin lymphomas in the western world. They can be further divided into three subtypes: extranodal MZL, splenic MZL, and nodal MZL. The
Externí odkaz:
https://doaj.org/article/fe5aad47d91e40fb88f27f264e4ae5d9
Autor:
Michael Robert Savona, James K Mccloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary-Margaret Keating, Nancy Y Zhu, Nashat Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy Dezern, Casey L Oconnell, Gail Roboz, Lambert Busque, Rena Buckstein, Harshad Amin, Jasleen K Randhawa, Brian Leber, Kim-Hien Dao, Winny Chan, Aram Oganesian, Yuri Sano, Beloo Mirakhur, Harold Keer, Guillermo Garcia-Manero
Publikováno v:
HemaSphere, Vol 7, p e1342620 (2023)
Externí odkaz:
https://doaj.org/article/d714ae49ea90429fa3bcf0183321b904
Autor:
Jennifer Teichman, Michelle Geddes, Nancy Zhu, Mary-Margaret Keating, Mitchell Sabloff, Grace Christou, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, April Shamy, Karen W.L. Yee, John M. Storring, Thomas J. Nevill, Robert Delage, Mohamed Elemary, Versha Banerji, Brett Houston, Lee Mozessohn, Lisa Chodirker, Liying Zhang, Mohammed Siddiqui, Anne Parmentier, Heather A. Leitch, Rena J. Buckstein
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
Iron overload (IO) reflected by elevated ferritin is associated with increased mortality in myelodysplastic syndromes (MDS), however, ferritin is an imperfect metric. Elevated labile plasma iron correlates with clinical outcomes and transferrin satur
Externí odkaz:
https://doaj.org/article/eaa39d28fdf24276b657fd4c5043b160
Autor:
Michael R. Savona, James K McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, Joachim Deeg, Prapti Patel, Mitchell Sabloff, Mary-Margaret Keating, Kim-Hien Dao, Nancy Zhu, Nashat Y. Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy E. DeZern, Casey L. O'Connell, Gail J. Roboz, Lambert Busque, Rena Buckstein, Harshad Amin, Jasleen K. Randhawa, Brian Leber, Aram Oganesian, Winny Chan, Yong Hao, Mohammad Azab, Guillermo Garcia-Manero
Publikováno v:
Blood. 140:2066-2069
Autor:
Rena Buckstein, Lisa Chodirker, Karen W.L. Yee, Michelle Geddes, Heather A. Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
Publikováno v:
Leukemialymphoma.
Many patients with lower-risk myelodysplastic syndromes (LR MDS) require long-term red blood cell (RBC) transfusions to manage anemia. The consequences of RBC transfusions in LR MDS with ring sideroblasts (LR MDS-RS) are not well known. We estimated
Autor:
Rena Buckstein, Lisa Chodirker, Lee Mozessohn, Karen W.L Yee, Michelle Geddes, Nancy Zhu, April Shamy, Heather A. Leitch, Grace Christou, Versha Banerji, Leber Brian, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Robert Delage, Anne Parmentier, Aksharh Thambipillai, Mohammed Siddiqui, Christopher Westcott, Chris Cameron, Alexandre Mamedov, Paul Spin, Derek Tang
Publikováno v:
Leukemialymphoma. 63(13)
Patients with lower-risk (LR) myelodysplastic syndromes (MDS) with ring sideroblasts (RS) have better prognosis than those without RS, but how they fare over time is not fully understood. This study's objective was to assess the natural history of LR
Autor:
Maria Agustina Perusini, Eshetu G. Atenafu, Donna L. Forrest, Bence-Bruckler Isabelle, Lynn Savoie, Mary-Margaret Keating, Lambert Busque, Robert Delage, Anargyros Xenocostas, Elena Liew, Pierre Laneuville, Kristjan Paulson, Tracy L. Stockley, Jeffrey H. Lipton, Brian Leber, Dennis Dong Hwan Kim
Publikováno v:
Blood. 140:6778-6779
Autor:
Igor Novitzky-Basso, Elena Liew, Eshetu G. Atenafu, Lambert Busque, Pierre Laneuville, Kristjan Paulson, Dennis Dong Hwan Kim, Mary-Margaret Keating, Isabelle Bence-Bruckler, Robert Delage, Suzanne Kamel-Reid, Tracy Stockley, Jeffrey H. Lipton, Donna L. Forrest, Brian Leber, Taehyung S Kim, Lynn Savoie, Anargyros Xenocostas
Publikováno v:
British Journal of Haematology. 193:779-791
Although total duration of tyrosine kinase inhibitor (TKI) therapy and of molecular response at 4 log reduction or deeper (MR4) correlates with treatment-free remission (TFR) success after TKI discontinuation, the optimal cut-off values of the durati
Autor:
Aksharh Kirubananthaan, Mohammad Siddiqui, Bo A Wan, Eve St-Hilaire, Karen W.L. Yee, Anne Parmentier, Versha Banerji, Mary-Margaret Keating, Mitchell Sabloff, Nancy Zhu, Thomas J. Nevill, Rebecca Starkman, Grace Christou, Michelle Geddes, Robert Delage, Aziz Nazha, Shabbir M.H. Alibhai, John M. Storring, Rena Buckstein, Mohamed Elemary, Brian Leber, Alexandre Mamedov, Liying Zhang, April Shamy, Heather A. Leitch, Richard A. Wells, Nicholas Finn, Lisa Chodirker
Publikováno v:
Leukemia. 34:3434-3438
Autor:
Dennis Dong Hwan Kim, Lambert Busque, Suzanne Kamel-Reid, Elena Liew, Anargyros Xenocostas, Igor Novitzky Basso, Mary-Margaret Keating, Lynn Savoie, Taehyung Simon Kim, Brian Leber, Tracy Stockley, Robert Delage, Donna L. Forrest, Pierre Laneuville, Kristjan Paulson, Jeffrey H. Lipton, Isabelle Bence-Bruckler, Eshetu G. Atenafu
Publikováno v:
British journal of haematologyReferences. 196(1)
The doubling time (DT) of the BCR-ABL1 quantitative polymerase chain reaction (qPCR) transcript level reflects the re-growing fraction of leukaemic cells after discontinuation of tyrosine kinase inhibitor (TKI). The present study analyzed monthly DT